CLINICAL_TRIALS
trial_result
· 2025-09-12
Clinical Trial Update: PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge [Phase 3]
Summary
Phase 3 trial of PH94B nasal spray for social anxiety disorder completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VistaGen Therapeutics, Inc. | Conditions: Social Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2025-09-12